CIED: cardiac implantable electronic device; FDG PET/CT: fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography; MRSA: methicillin-resistant Staphylococcus aureus; SPECT/CT: radiolabeled autologous white blood cell single-photon emission computed tomography with computed tomography; TEE: transesophageal echocardiogram.
* Blood cultures should be obtained prior to antibiotic administration. Blood cultures obtained following antibiotic administration may be falsely negative; refer to UpToDate text for further discussion.
¶ Noninfectious causes of erythema or other skin/soft tissue abnormalities at the CIED pocket site include local bleeding, reaction to a wound dressing or skin preparation, retained suture, or allergy to device components.
Δ If available, FDG PET/CT may be useful to distinguish between CIED pocket infection and superficial site infection in some circumstances; refer to UpToDate topic on diagnosis of CIED infection for further discussion.
◊ Oral antibiotic dosing as follows:§ Vancomycin dosing: 15 to 20 mg/kg/dose intravenously every 8 to 12 hours (not to exceed 2 g per dose); refer to UpToDate text for discussion of alternative agents.
¥ TEE demonstrating vegetation is consistent with CIED systemic infection; such patients should receive antibiotic therapy according to approach for endocarditis. Refer to UpToDate text for further discussion.
‡ Swabs and tissue from the pocket should be sent for culture, in addition to lead tips.
† For fungal CIED pocket infection, the duration of antifungal therapy is four weeks following device removal. Refer to UpToDate text for further discussion of treatment for CIED infection.